GSK, CureVac team up to develop vaccine against COVID-19 variants | Reuters
Europe Coronavirus Updates: 22 schools in France closed due to coronavirus, CureVac expected to produce 100 mln doses of vaccine by year end - Xinhua | English.news.cn
CureVac teams up with Bayer to accelerate development of Covid vaccine
News - Press Releases and Announcements - Detail - Rentschler Biopharma SE
BMWK - Federal Government to contribute 300 million euros to CureVac
Homepage - CureVac
Downloads - CureVac
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3WRJIXZFNNJABBELXITXNDPKEM.jpg "EU regulator does not expect approval for CureVac vaccine before August - source | Reuters")
EU regulator does not expect approval for CureVac vaccine before August - source | Reuters
CureVac GmbH: RNA-based vaccines and immunotherapies
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QT4XC3UAZBMIBPFR363YMFOMPQ.jpg "CureVac's pain may not yet have peaked | Reuters")
CureVac's pain may not yet have peaked | Reuters
GSK, CureVac team up to develop vaccine against COVID-19 variants | Reuters
CureVac stock tumbles after its mRNA vaccine falls well short of Pfizer and Moderna rivals | Fortune
The Tübingen-based biotech company CureVac is developing a coronavirus vaccine. A site visit. | KfW Stories
CureVac launches large-scale Covid vaccine trial | Financial Times
Become part of the RNA people - CureVac
CureVac CEO Interview, Coronavirus Vaccine Development, Controversy
The CureVac Story
About Us - CureVac
CureVac to Participate in Two Panels at the ROTH RNA Revolution Conference - CureVac
/cloudfront-us-east-2.images.arcpublishing.com/reuters/TWWD6JXQBZJ3LADCYZ3TI4AGCM.jpg "CureVac's COVID-19 vaccine attracts rising interest | Reuters")
CureVac's COVID-19 vaccine attracts rising interest | Reuters
How vaccine laggard CureVac hopes to come out on top | Financial Times
CureVac's COVID-19 vaccine triggers immune response in Phase I trial | Reuters
CureVac | Facebook
Contact - CureVac
GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants - The Economic Times
CureVac's COVID-19 vaccine attracts rising interest | CTV News
Celonic and CureVac Partnership to Manufacture COVID-19 Vaccine
Germany: EIB and European Commission provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing
